LinkedIn image ad examples

Even small workflow inefficiencies can impact sample integrity, traceability, and productivity. Our Sample Tube Workflow Guide helps you identify opportunities for improvement at every stage. Download the guide today.

Stop switching between programming tools and visualization platforms. In Ageirein™, R, SAS®, Python, and Shiny run together - and your apps link directly to the project.

New connections pull study data straight from your EDC into Ageirein™ in one step - no manual exports, no waiting.

Still counting organoids one well at a time? When cultures scale, manual counting quickly becomes part of the experiment itself — recounting wells, keeping track of numbers, and trying to maintain consistency across timepoints. Omni automatically detects and counts organoids across the well, so you can spend less time counting and more time using the data.

How many organoids are you counting by hand? When cultures scale, manual counting quickly becomes part of the experiment itself — recounting wells, keeping track of numbers, and trying to maintain consistency across timepoints. Omni automatically detects and counts organoids across the well, so you can spend less time counting and more time using the data.

Start with a sign-on bonus – up to $8,000 for new RNs! Aultman Hospital in Canton is hiring new RN grads in a variety of units. Enjoy competitive wages, up to $5,000 in loan forgiveness and a one-year new nurse residency program. We know you will appreciate the collaborative team culture, robust training and mentorship. As a nonprofit, you are eligible for public service loan forgiveness too! No BSN is required — just bring your passion for patient care and great ready to grow!

AI is rapidly transforming pharmacovigilance, but not every technology partner is prepared to deliver enterprise-scale results. Join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward fully AI-powered PV operations.

#AscendisPharma is proud to be funding “Closing the Policy Gap in Rare Diseases: The Case of Hypoparathyroidism,” an event hosted by Pascal Arimont at the European Parliament in Brussels. #Hypoparathyroidism is a rare endocrine disease that is linked to multi-organ manifestations and can cause a wide range of symptoms and complications. This hybrid event brings patients, advocates, clinical experts, and policymakers together to discuss the unmet needs of people living with hypoparathyroidism and explore EU policy pathways around #RareDiseases, #WomensHealth, #BrainHealth and #HealthEquity. 📅 September 30 | 13:30–15:30 CEST 📍 European Parliament, Brussels (in-person and online) 👉 Learn more and register: https://lnkd.in/eUAdQRVY

Wil jij een belangrijke rol spelen in onze HR-ontwikkeling? Als HR Specialist Beleid & Projecten bij Auris vertaal jij strategische vraagstukken naar een gedegen beleid én succesvolle projecten. Samen met je collega's bouw je aan een werkomgeving waarin onze onderwijs- en zorgprofessionals optimaal kunnen presteren en groeien. 👉 Bekijk de vacature en solliciteer direct!

Het HR-beleid vormgeven én het succesvol uitrollen in de praktijk? Dat is jouw rol als HR Specialist Beleid & Projecten bij Auris! Wat ga je doen? ✅ Ontwikkelen en vernieuwen van HR-beleid ✅ Leiden van impactvolle HR-projecten ✅ Adviseren en samenwerken met sleutelspelers binnen Auris Bij Auris kom je samen tot bloei. Ontdek de vacature en versterk ons team! 👇

We are excited to be at EACTS 2026 and look forward to connecting with you in Barcelona! Visit us at Booth #76 and meet our expert Milena Ntreou, who will be on site to discuss our latest innovations and how our solutions are helping to redefine possibilities in aortic care. Stop by, ask your questions and share your perspective – we look forward to seeing you there! https://lnkd.in/eEABp9Gm #ArtivionEMEA

Don't delay your research discoveries by scoping your TRE build when you can start using the Aridhia DRE now. Building a Trusted Research Environment to the standards expected by modern research projects takes a lot of time and money, we know this because we've built the Aridhia DRE. Our ISO 27001 / 27701 certified TRE has out-of-the-box federation and FL support and secure and governed AI for research. It also comes with powerful built-in tooling or you can bring your own. The Aridhia DRE is already in use by research hospitals, global consortia, and life sciences organisations across more than 110 countries. It's ready for your research now.

Don't delay your research discoveries by scoping your TRE build when you can start using the Aridhia DRE now. Building a Trusted Research Environment to the standards expected by modern research projects takes a lot of time and money, we know this because we've built the Aridhia DRE. Our ISO 27001 / 27701 certified TRE has out-of-the-box federation and FL support and secure and governed AI for research. It also comes with powerful built-in tooling or you can bring your own. The Aridhia DRE is already in use by research hospitals, global consortia, and life sciences organisations across more than 110 countries. It's ready for your research, now.

For decades, double programming has been the gold standard for validating clinical tables. It earned that position because it provided an independent way to verify results and protect quality. That hasn't changed. What has changed is the environment in which biometrics teams work. Today, teams face: • More studies and increasingly complex data • Shorter timelines and higher delivery expectations • Growing workloads with limited programming resources • Faster regulatory and submission cycles Yet quality control remains one of the biggest bottlenecks on the path to submission-ready outputs. Traditional double programming and manual validation create repetitive, siloed workflows that demand significant expert time. Verify Intelligence introduces a new approach to independent validation. Using GenAI, it interprets study documents, including SAPs, mock shells, specifications, and structured ADaM datasets, to independently generate validation tables for expert review. Each generated table is supported by: ➝ Transparent metadata interpretation ➝ Explainable AI reasoning ➝ SQL logic behind the generated result ➝ Confidence and gap analysis ➝ Complete traceability and audit history Instead of duplicating programming effort, biometrics teams gain an independently generated set of validation tables that supports faster comparison, validation, and review within a transparent, governed workflow. Independent validation remains the standard. What's changing is how it's achieved. GenAI. Verified.

Nieuwsgierig naar werken bij de crisisdienst als verpleegkundige? Soms wil je eerst sfeer proeven, vragen stellen en ervaringen uit de praktijk horen. Daarom organiseren we 'Koffie met de Crisisdienst': een persoonlijk gesprek met een ervaren verpleegkundige die je alles kan vertellen over werken binnen de Spoedeisende Psychiatrie Amsterdam. Stel al je vragen aan een collega-verpleegkundige. Hoor een eerlijk verhaal uit de praktijk. Een laagdrempelige manier om kennis te maken met ons vak en ons team.

Een nieuwe stap als verpleegkundige begint vaak met nieuwsgierigheid. Hoe ziet een dienst bij de crisisdienst eruit? Hoe werk je samen met andere disciplines? Wat maakt de acute psychiatrie zo dynamisch? Tijdens 'Koffie met de Crisisdienst' ga je één-op-één in gesprek met een ervaren verpleegkundige. Een open kennismaking met alle ruimte voor jouw vragen. Ontdek of werken bij de crisisdienst bij jou past.

Primary care doesn't run on one workflow. A single day can swing from a wellness visit to an urgent need to a chronic care follow-up, all through the same front desk. Off-the-shelf AI agents apply one script no matter which it is. Artera's AI Service Squad builds your scheduling and outreach workflow around how your practice actually runs, not a generic template.

Your patients need to trust their communication is handled with care. Artera's Voice AI Agents are built especially for behavior health, so your practice maintains trust and saves time.

Why Collagen Peptides Are Gaining Attention in Active Nutrition The future of nutrition is becoming more active. As consumers focus on movement, wellness, and long-term health, brands are exploring new opportunities in functional nutrition. Collagen peptides are becoming an ingredient of interest for products targeting: 💪 Active lifestyles 🏃 Sports nutrition 🌿 Healthy aging For product developers, the opportunity is not only about choosing an ingredient. It is about creating solutions that match evolving consumer expectations. Collagen peptides are becoming part of the next generation of wellness products. Arshine Lifescience (USA) | Your Trusted Ingredient Partner 🌍 https://www.arshineusa.com 📧[email protected] ☎(848)468-0481 #CollagenPeptides #FunctionalNutrition #Nutraceuticals #DietarySupplements #ProductInnovation

Beyond Beauty: The Growing Opportunity of Healthy Aging Nutrition Collagen has long been associated with beauty products. But the market is changing. Today’s consumers are looking for solutions that support a more active and holistic approach to wellness. This shift is creating new opportunities for collagen peptides in areas such as: ✨ Skin wellness 🦴 Healthy aging 💪 Active lifestyle nutrition For brands, understanding changing consumer needs is key to developing products that stay relevant in the evolving wellness market. The next chapter of collagen is expanding beyond beauty. Arshine Lifescience (USA) | Your Trusted Ingredient Partner 🌍 https://www.arshineusa.com 📧[email protected] ☎(848)468-0481 #CollagenPeptides #FunctionalNutrition #Nutraceuticals #DietarySupplements #ProductInnovation

𝗙𝗼𝘂𝗿 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗔𝗜 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝘄𝗲𝗿𝗲 𝘁𝗿𝗮𝗰𝗸𝗲𝗱 𝗳𝗼𝗿 𝘂𝗽 𝘁𝗼 𝘁𝘄𝗼 𝘆𝗲𝗮𝗿𝘀 𝗮𝗳𝘁𝗲𝗿 𝗴𝗼-𝗹𝗶𝘃𝗲. 𝗔𝗹𝗹 𝗳𝗼𝘂𝗿 𝗱𝗿𝗶𝗳𝘁𝗲𝗱 𝗮𝘄𝗮𝘆 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲𝗶𝗿 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲. 𝗧𝗵𝗲 𝗺𝗼𝗱𝗲𝗹𝘀 𝗻𝗲𝘃𝗲𝗿 𝗰𝗵𝗮𝗻𝗴𝗲𝗱. That is a peer-reviewed study published in PLOS Digital Health on July 27, covering four deployed systems inside one large healthcare organization, across 68,000 to 1,240,000 inference events each. Same models, same thresholds, same intended uses. The first thing to go was calibration. Ranking held up, so the systems still sorted patients in roughly the right order while the absolute risk numbers quietly stopped being right. The paper calls it silent miscalibration, and it is the kind of failure a dashboard of accuracy metrics will not show you. What tracked with the degradation was workflow-associated change in data availability and timing. Inputs that used to arrive started arriving late, or stopped arriving. The paper found that association stronger and more consistent than anything measured at the population level. Those operational signals showed the problem earlier than outcome-based monitoring did, because outcome labels wait on documentation and arrive long after the decision. So the earliest warning that a clinical model is going wrong shows up in the data layer, and most teams are watching the model layer. Four systems in one organization, and the authors say that the effect sizes should not be read as universal failure rates for clinical AI. What carries is the failure structure, repeating across four systems in different clinical domains and workflows. Axiomera AI works on the layer the paper points at. Every field is bound to shared clinical terminologies as it arrives, with a confidence score and lineage on the value itself, so the binding travels with the record. Sources reconcile into one governed layer, all of it inside your own environment. Raw data never leaves it and nothing is rewritten at the source. That does not monitor your model. It makes the ground your model stands on legible, so when an input changes what it means or when it shows up, that is a thing you can see and re-derive. Today most teams learn it months later, from an outcome. The paper is in the first comment. #HealthcareAI #DataGovernance

Enquanto o setor discute o futuro da medicina laboratorial no SBPC/ML 2026, alguns gargalos da operação já têm solução prática — hoje.

A inovação discutida no CBPC/ML 2026 já pode ser aplicada na rotina operacional do seu laboratório — sem complicar o dia a dia da equipe.

Thank you to everyone who visited the Ascendis Pharma booth during the 64th Annual Meeting of the European Society for Paediatric Endocrinology #ESPE2026. We were delighted to connect with the endocrinology community for conversations centered on the impact of #achondroplasia on bone and beyond, and the importance of seeing the condition through the eyes of those living with it every day. By stepping into a space designed around children with #achondroplasia, attendees were invited to hear directly from children and families and experience a more personal perspective on the realities of living with the condition. What was your highlight from this year’s meeting?